Technology
Health
Biotechnology

Voyager Therapeutics

$22.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell VYGR and other stocks, options, ETFs, and crypto commission-free!

About

Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. Read More The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

Employees
123
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
835.76M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
430.93K
High Today
$23.29
Low Today
$22.05
Open Price
$22.60
Volume
107.08K
52 Week High
$25.74
52 Week Low
$7.76

Collections

Technology
Health
Biotechnology
Therapy
Medical
2015 IPO
US
North America

News

Yahoo FinanceMay 7

Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -2.53% and 73.06%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

188
NasdaqMay 2

Analysts Estimate Voyager Therapeutics (VYGR) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on higher revenues when Voyager Therapeutics (VYGR) reports results for the quarter ended March 2019. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

231
Simply Wall StApr 30

Investors Who Bought Voyager Therapeutics (NASDAQ:VYGR) Shares Three Years Ago Are Now Up 79%

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger returns, and build a portfolio ourselves. For example, Voyager Therapeutics, Inc. (NASDAQ:VYGR) shareholders have seen the share price rise 79% over three years, well in excess of the market return (41%, not including dividends). However, more recent returns haven’t been as ...

228

Earnings

-$0.89
-$0.40
$0.09
$0.58
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.